We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
Observational study examines real-world outcomes of ticagrelor versus prasugrel in patients undergoing percutaneous coronary intervention for NSTEMI, highlighting practical antiplatelet selection.
No takes yet. Share an insight, caveat, or question.
Sucato et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: